Characterization of KRAS rearrangements in metastatic prostate cancer

Cancer Discovery

Volumn 1, Issue 1, 2011, Pages 35-43

  Wang, Xiao Song ^a   Shankar, Sunita ^a   Dhanasekaran, Saravana M ^a   Ateeq, Bushra ^a   Sasaki, Atsuo T ^c,d   Jing, Xiaojun ^a   Robinson, Daniel ^a   Cao, Qi ^a   Prensner, John R ^a   Yocum, Anastasia K ^a   Wang, Rui ^a   Fries, Daniel F ^a   Han, Bo ^a   Asangani, Irfan A ^a   Cao, Xuhong ^a   Li, Yong ^a   Omenn, Gilbert S ^a   Pflueger, Dorothee ^b   Gopalan, Anuradha ^b   Reuter, Victor E ^b   Kahoud, Emily Rose ^c   Cantley, Lewis C ^c,d   Rubin, Mark A ^b   Palanisamy, Nallasivam ^a   Varambally, Sooryanarayana ^a   Chinnaiyan, Arul M ^a   more..

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; RAF PROTEIN; UBIQUITIN CONJUGATING ENZYME E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL PROLIFERATION; CELL STRAIN 3T3; CHROMATIN ASSEMBLY AND DISASSEMBLY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENE FUSION; GENE REARRANGEMENT; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METASTASIS; MOUSE; MUTATION; NONHUMAN; NUCLEASE PROTECTION ASSAY; ONCOGENE K RAS; ONCOGENE RAS; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE FUSION; GENE REARRANGEMENT; HEK293 CELLS; HUMANS; MALE; MAP KINASE KINASE KINASES; MICE; MUTATION; NIH 3T3 CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS P21(RAS); RAS PROTEINS; UBIQUITIN-CONJUGATING ENZYMES;

EID: 84864198793     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8274.CD-10-0022     Document Type: Article

References (24)

1. Wang XS, Prensner JR, Chen G, Cao Q, Han B, Dhanasekaran SM, et al. An integrative approach to reveal driver gene fusions from pairedend sequencing data in cancer. Nat Biotechnol 2009;27:1005-11.
2. Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-4.
3. Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet 2004;36:1084-9.
4. Barr FG, Nauta LE, Davis RJ, Schafer BW, Nycum LM, Biegel JA. In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma. Hum Mol Genet 1996;5:15-21.
5. Ferreira BI, Alonso J, Carrillo J, Acquardo F, Largo C, Suela J, et al. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma. Oncogene 2008;27:2084-90.
6. Koivunen JP, Mermel C, Zejnullahu K, Murphy C, Lifshits E, Holmes AJ, et al. EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008;14:4275-83.
7. Stergianou K, Fox C, Russell NH. Fusion of NUP214 to ABL1 on amplified episomes in T-ALL-implications for treatment. Leukemia 2005;19:1680-1.
8. Attard G, Clark J, Ambroisine L, Fisher G, Kovacs G, Flohr P, et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene 2008;27:253-63.
9. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008;9:517-31.
10. Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F. Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol 2005;70:461-7.
11. Moul JW, Friedrichs PA, Lance RS, Theune SM, Chang EH. Infrequent RAS oncogene mutations in human prostate cancer. Prostate 1992;20:327-38.
12. Seeburg PH, Colby WW, Capon DJ, Goeddel DV, Levinson AD. Biological properties of human c-Ha-ras1 genes mutated at codon 12. Nature 1984;312:71-5.
13. Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007;7:295-308.
14. Wu SQ, Voelkerding KV, Sabatini L, Chen XR, Huang J, Meisner LF. Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562. Leukemia 1995;9:858-62.
15. Graff JR, Konicek BW, McNulty AM, Wang Z, Houck K, Allen S, et al. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem 2000;275:24500-5.
16. Gioeli D, Kraus S, Weber MJ. Signal transduction by the Ras-MAP kinase pathway in prostate cancer progression. In: Nevalainen MT, Pestell RG, editors. Current clinical oncology: prostate cancer: signaling networks, genetics, and new treatment strategies. Totowa, NJ: Humana Press; 2008. p. 223-56.
17. Xu L, Chen S, Bergan RC. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer. Oncogene 2006;25:2987-98.
18. Moynihan TP, Cole CG, Dunham I, O'Neil L, Markham AF, Robinson PA. Fine-mapping, genomic organization, and transcript analysis of the human ubiquitin-conjugating enzyme gene UBE2L3. Genomics 1998;51:124-7.
19. Der CJ, Krontiris TG, Cooper GM. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci U S A 1982;79:3637-40.
20. Li W, Zhu T, Guan KL. Transformation potential of Ras isoforms correlates with activation of phosphatidylinositol 3-kinase but not ERK. J Biol Chem 2004;279:37398-406.
21. Palanisamy N, Ateeq B, Kalyana-Sundaram S, Pflueger D, Ramnarayanan K, Shankar S, et al. Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. Nat Med 2010;16:793-8.
22. Olshen AB, Venkatraman ES Lucito R, Wigler M. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004;5:557-72.
23. Kleer CG, Cao Q, Varambally S, Shen R, Ota I, Tomlins SA, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A 2003;100:11606-11.
24. Varambally S, Cao Q, Mani RS, Shankar S, Wang X, Ateeq B, et al. Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science 2008;322:1695-9.